Tipsheet
What matters at India’s listed companies
Earnings · Finance - Investment · Micro cap

Arunjyoti Bio Ventures swings to profit, proposes rename to Pasura Industries

After a loss-making March quarter, the nano-cap reports ₹8.20 cr revenue and ₹0.61 cr net profit. Board also seeks shareholder nod for a name change and higher director pay.


Mkt cap₹105 cr
ROE0.00%
Debt / eq.0.79
₹0.61 cr Q1 FY27 net profit after loss-making March quarter

What's new

  • Revenue of ₹8.20 cr and net profit of ₹0.61 cr for June quarter
  • Board proposes rename to Pasura Industries Limited, subject to shareholder approval
  • Waived ₹25.19 lakh excess remuneration; raised three directors' salaries to ₹8 lakh and ₹5 lakh per month

Why this matters

For a nano-cap with ₹105 cr market cap and high debt, the sharp turnaround from loss to profit signals operational improvement. The rebranding hints at a strategic shift, but the salary hikes and waiver raise governance scrutiny. Sustaining profitability is the key test.

What we're watching

  • Shareholder vote on name change at 12 Aug 2026 AGM
  • Q2 FY27 performance to confirm trend
  • Debt reduction progress given 0.79 debt/equity ratio

The full read

Arunjyoti Bio Ventures has posted a sharp reversal. For the quarter ended June 2026, it reported a net profit of ₹0.61 crore on revenue of ₹8.20 crore, swinging from a loss in the March quarter. Total income rose to ₹8.22 crore while expenses fell, producing an operating profit of ₹0.82 crore. The board also proposed renaming the company to Pasura Industries Limited — a move that suggests a change in identity, perhaps beyond the bio-ventures label. But alongside that came a waiver of ₹25.19 lakh in excess managerial remuneration paid in FY26 and salary hikes for three directors to ₹8 lakh, ₹5 lakh and ₹5 lakh per month, each with ₹10 lakh travel allowance. For a nano-cap with ₹105 crore market cap and debt of 0.79 times equity, the profit is welcome but the governance optics are mixed. The next quarter will show whether the turnaround has legs. The AGM on 12 August 2026 will test shareholder sentiment on the name change and the pay packets.

Questions answered

What drove the swing to profit?
Total income rose sequentially to ₹8.22 crore while expenses declined sharply, producing an operating profit of ₹0.82 crore and a net profit of ₹0.61 crore.
Why is the company changing its name?
The board proposed renaming to Pasura Industries Limited, indicating a strategic shift. The change requires shareholder approval at the AGM on 12 August 2026.
What are the new director salaries?
Three whole-time directors will receive ₹8 lakh, ₹5 lakh, and ₹5 lakh per month, each with an annual leave travel allowance of up to ₹10 lakh.
What was the excess remuneration waiver about?
The board waived ₹25.19 lakh in excess managerial remuneration paid to two whole-time directors during FY2026.
Is this turnaround sustainable?
One quarter of profit does not confirm a trend, especially given trailing PAT growth of -426.4%. The next quarter will be critical to assess sustainability.
When is the annual general meeting?
The 40th AGM is scheduled for 12 August 2026, where shareholders will vote on the name change and other resolutions.
Mentioned: ₹8.20 cr revenue · Pasura Industries Limited · 12 August 2026
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Arunjyoti Bio Ventures Ltd.

Asset Management
₹106 cr

Latest quarter · Dec 2010

Total income₹0 cr
Net profit₹0 cr
Net margin+22.3%
EPS₹0.00

Leverage & growth

Debt / equity0.79×
Sales CAGR+62.7%
Financials via Tijori — a research aid, not investment advice.ABVL on Tijori